ES2153584T3 - Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos. - Google Patents

Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.

Info

Publication number
ES2153584T3
ES2153584T3 ES96920335T ES96920335T ES2153584T3 ES 2153584 T3 ES2153584 T3 ES 2153584T3 ES 96920335 T ES96920335 T ES 96920335T ES 96920335 T ES96920335 T ES 96920335T ES 2153584 T3 ES2153584 T3 ES 2153584T3
Authority
ES
Spain
Prior art keywords
piridiniminil
benzisotiazol
benzisoxazol
antipsychotics
benzisoxazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96920335T
Other languages
English (en)
Inventor
David M Fink
Barbara E Kurys
Gregory M Shutske
John D Tomer Iv
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2153584T3 publication Critical patent/ES2153584T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE DESCRIBEN NUEVOS PIRIDINIMINIL - 1,2 - BENZISOXAZOLES Y BENZISOTIAZOLES Y PROCEDIMIENTOS PARA SU PREPARACION, Y PROCEDIMIENTOS PARA ALIVIAR LA DISFUNCION DE LA MEMORIA Y PARA TRATAR LA DEPRESION UTILIZANDO LOS 1,2 - BENZISOXAZOLES Y BENZISOTIAZOLES Y LOS INTERMEDIOS, O COMPOSICIONES DE LOS MISMOS.
ES96920335T 1995-06-06 1996-05-14 Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos. Expired - Lifetime ES2153584T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46602195A 1995-06-06 1995-06-06
US08/637,091 US5668154A (en) 1995-06-06 1996-05-02 Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles

Publications (1)

Publication Number Publication Date
ES2153584T3 true ES2153584T3 (es) 2001-03-01

Family

ID=23850131

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96920335T Expired - Lifetime ES2153584T3 (es) 1995-06-06 1996-05-14 Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.

Country Status (17)

Country Link
US (3) US5668154A (es)
EP (1) EP0848713B1 (es)
KR (1) KR100309215B1 (es)
AR (1) AR002204A1 (es)
AT (1) ATE197153T1 (es)
AU (1) AU708843B2 (es)
CA (1) CA2224171A1 (es)
DE (1) DE69610778T2 (es)
DK (1) DK0848713T3 (es)
ES (1) ES2153584T3 (es)
GR (1) GR3035249T3 (es)
HU (1) HUP9802571A3 (es)
NO (1) NO975682L (es)
NZ (1) NZ308831A (es)
PT (1) PT848713E (es)
TW (1) TW355710B (es)
ZA (1) ZA964565B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
GT199900185A (es) 1998-11-06 2001-04-18 Novedosa pirimidin-4-enamina como fungicida.
US6123554A (en) * 1999-05-28 2000-09-26 Berg Technology, Inc. Connector cover with board stiffener
US9907751B2 (en) * 2016-03-10 2018-03-06 RxOMEG Therapeutics LLC Composition and method of use of colchicine oral liquid
US10226423B1 (en) 2017-12-20 2019-03-12 RxOMEG Therapeutics LLC Colchicine drug-to-drug interactions
CN110117278B (zh) * 2018-02-07 2022-07-19 石家庄以岭药业股份有限公司 烷氧基苯并五元(六元)杂环胺类化合物及其药物用途
WO2023083445A1 (en) 2021-11-10 2023-05-19 Symrise Ag Compositions comprising trpm8 agonistic cooling agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds

Also Published As

Publication number Publication date
DK0848713T3 (da) 2000-12-18
CA2224171A1 (en) 1996-12-12
ZA964565B (en) 1996-12-12
US5728717A (en) 1998-03-17
AU708843B2 (en) 1999-08-12
MX9709450A (es) 1998-06-28
KR100309215B1 (ko) 2001-12-28
KR19990022265A (ko) 1999-03-25
AR002204A1 (es) 1998-01-07
EP0848713B1 (en) 2000-10-25
HUP9802571A2 (hu) 1999-08-30
DE69610778D1 (de) 2000-11-30
GR3035249T3 (en) 2001-04-30
US5668154A (en) 1997-09-16
EP0848713A1 (en) 1998-06-24
AU5867796A (en) 1996-12-24
DE69610778T2 (de) 2001-06-13
TW355710B (en) 1999-04-11
US5948798A (en) 1999-09-07
NO975682D0 (no) 1997-12-05
HUP9802571A3 (en) 1999-11-29
PT848713E (pt) 2001-02-28
NO975682L (no) 1998-02-05
NZ308831A (en) 1998-11-25
ATE197153T1 (de) 2000-11-15

Similar Documents

Publication Publication Date Title
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
DK0751789T3 (da) Gel til behandling af hudsygdomme og til desinfektion af huden
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
DE69429524D1 (de) Aminocyclohexylester und ihre anwendung
PT946507E (pt) Compostos de pirrolilo substituidos para o tratamento da inflamacao
ES2184794T3 (es) Profarmacos de morfolina como antagonistas de receptores de taquicininas.
MY121548A (en) Compounds and methods for the treatment of cancer
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR9507730A (pt) Uso de formulações em gel como composições de tratamento
ES2221950T3 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
ES2123714T3 (es) Aislamiento y estructura de las esponjistatinas 5,7,8 y 9 y su empleo como agentes antitumorales.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ES2153584T3 (es) Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ES2193248T3 (es) Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
AR006084A1 (es) Aminofeniluracilos substituidos y empleo de los mismos para la lucha contra las plantas indeseables
ATE259886T1 (de) Ledergerben

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 848713

Country of ref document: ES